|
|||
2011-03-22 14:45:00 CET 2011-03-22 14:45:28 CET REGULATED INFORMATION Biotie Therapies - Major shareholder announcementsNotification according to Chapter 2, Section 10 of the Finnish Securities Market ActBIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 22 March 2011 at 3.45 p.m. Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act Biotie Therapies Corp. ("Company" or "Biotie") has gained knowledge of a notification regarding changes in holdings in accordance with Chapter 2, Section 9 of the Finnish Securities Markets Act, described below. The notification received by the Company concerns the changes in holdings of Invesco Limited (through Invesco Fund Managers Limited) The mentioned change in holdings is related to the private placement of shares (the "Offering") described in more detail in a stock exchange release issued on 11.3.2011. In the Offering a total of 35,230,000 newly issued and 14,747,084 treasury shares were offered to Finnish and international institutional and strategic investors. As a result of the Offering and the registration of the offered new shares with the Finnish Trade Register on 18 March 2011, the resulting holdings of shares and votes in the Company of Invesco Limited (through Invesco Fund Managers Limited) is as follows: Name Number of Number of Number of Share of Share of shares before voting rights shares and share voting the Offering before the voting rights capital rights Offering after the after the after the Offering Offering Offering (%) (%) Invesco 14,432,000 14,432,000 44,273,256 11.42 % 11.88 % Limited (through Invesco Fund Managers Limited) Total 14,432,000 14,432,000 44,273,256 11.42 % 11.88 % The number of voting rights and percentages presented above are calculated taking into account the treasury shares held by the Company or its group companies at the date of this release. As a result of the Offering and the registration of the new shares offered, the share of voting rights, calculated taking into account the treasury shares held by the Company or its group companies, of both 5AM Partners LLC (through 5AM Ventures LLC and 5AM Co-Investors LLC) and Abingworth Management Limited (through Abingworth Bioventures IV LP and Abingworth Bioventures IV Executives LP) have, according to the Company's knowledge, fallen below 5 %. The share of the share capital of both above mentioned shareholders remains below 5 %. On the date hereof, the registered number of shares in Biotie is 387,594,457. Of these shares, 14,912,155 are held by the Company or its group companies. Turku, 22 March 2011 Biotie Therapies Corp. Timo Veromaa President and CEO For further information, please contact: Virve Nurmi, Biotie Therapies Corp. tel. +358 2 274 8900 e-mail:virve.nurmi@biotie.com DISTRIBUTION NASDAQ OMX Helsinki Ltd Main Media www.biotie.com [HUG#1499031] |
|||
|